Emergence of carbapenemase KPC-14 in an <i>Escherichia coli</i> isolate: a case report. [PDF]
Fontán García-Rodrigo L +4 more
europepmc +1 more source
Reduced Susceptibility to Cefiderocol Among Clinical MCR-1-Producing <i>Escherichia coli</i> Isolates from Tunisia. [PDF]
Jaidane N +12 more
europepmc +1 more source
<i>In vitro</i> activities of aztreonam/nacubactam and cefepime/nacubactam against a global collection of molecularly characterized Enterobacterales isolates carrying carbapenemases: a global antimicrobial resistance surveillance study from 2021 to 2023. [PDF]
Estabrook M +3 more
europepmc +1 more source
Mechanisms involved in cefiderocol resistance in French <i>Pseudomonas aeruginosa</i> clinical strains. [PDF]
Gauthier E +9 more
europepmc +1 more source
Real-World Use of Cefiderocol for Multidrug-Resistant Gram-Negative Infections in Critically Ill ICU Patients: A Single-Center Case Series. [PDF]
Ritiu SA +9 more
europepmc +1 more source
Genomic and structural insights into the in vivo development of cefiderocol resistance in Klebsiella pneumoniae. [PDF]
Tristancho-Baró A +11 more
europepmc +1 more source
Carbapenemases in Gram-Negative Bacilli: Classification, Detection, Therapeutic Options, and Resistance to Novel Antimicrobials. [PDF]
Vulpie S +7 more
europepmc +1 more source
Cefiderocol Susceptibility in Japanese Clinical Enterobacterales Isolates and the Effect of IMP-Type Carbapenemases on Resistance. [PDF]
Cai M +7 more
europepmc +1 more source
Comparative evaluation of the activity of novel β-lactam antibiotics against difficult-to-treat <i>Pseudomonas aeruginosa</i> clinical isolates. [PDF]
Mystakelis H +7 more
europepmc +1 more source
Characterization of the intrinsic AmpC β-lactamase of Escherichia marmotae and its impact on decreased susceptibility to cefiderocol and resistance to broad-spectrum cephalosporins. [PDF]
Freire S +5 more
europepmc +1 more source

